MedPath

Effect of Over-the-counter Dietary Supplements on Kidney Stone Risk

Not Applicable
Completed
Conditions
Hyperoxaluria
Interventions
Dietary Supplement: Bilberry
Dietary Supplement: Cranberry
Dietary Supplement: Aloe vera with cactus
Dietary Supplement: Cinnamon
Dietary Supplement: Green tea extract
Dietary Supplement: Milk thistle
Dietary Supplement: Turmeric
Dietary Supplement: Aloe vera
Registration Number
NCT02404701
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

The purpose of this study is to ascertain whether certain supplements promote excessive urinary oxalate excretion and increase the risk for calcium oxalate kidney stones. Supplements that enhance urinary oxalate excretion, as a result of their oxalate concentration or from some other mechanism (e.g., providing substrate for oxalate biosynthesis) will be identified by the investigators.

Detailed Description

The investigators hypothesize that certain over-the-counter dietary supplements will increase urinary excretion of oxalate as measured in 24-h urine collections. The investigators further hypothesize that the concentration of oxalate in dietary supplements may not be associated with urinary oxalate excretion, suggesting that other nutritional components of the supplements may be exerting an influence over oxalate biosynthesis, oxalate absorption in the gastrointestinal tract, and/or renal oxalate handling. These other factors include the form of oxalate in the supplement (water- vs. non water-soluble) and the supplement's concentration of ascorbic acid.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • At least 18 years of age, no prior personal history of kidney stones
Exclusion Criteria
  • Personal history of kidney stones (by subjects' report); known allergy to any of the dietary supplements to be used in the study (by subjects' report); short bowel; active ulcerative colitis or irritable bowel disease; Crohns or Celiac disease; renal tubular acidosis; current use of topiramate or other carbonic anhydrase inhibitor, steroids, allopurinol, thiazide diuretics, or supplemental ascorbic acid >250 mg/day.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
BilberryBilberry1 softgel (1000 mg), 2 times/day
CranberryCranberry3 capsules (810 mg), 2 times/day
Aloe vera with cactusAloe vera with cactus1 capsule (500 mg), 2 times/day
CinnamonCinnamon1 capsule (500 mg), 2 times/day
Green tea extractGreen tea extract2 capsules (630 mg), 2 times/day
Milk thistleMilk thistle1 capsule (250 mg), 3 times/day
TurmericTurmeric1 capsule (450 mg turmeric + 50 mg turmeric extract), 1 time/day
Aloe veraAloe vera1 capsule (470 mg), 2 times/day
Primary Outcome Measures
NameTimeMethod
Within-subject change in 24-hour urinary oxalate excretion from before and after supplementation7 days

24-hour urine samples will be analyzed for oxalate by ion chromatography. The difference in oxalate between the baseline (non-supplement) and supplement phase will be assessed.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Urology, School of Medicine & Public Health, University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath